XML 75 R61.htm IDEA: XBRL DOCUMENT v3.19.1
LOSS PER SHARE (Tables)
 12 Months Ended
Dec. 31, 2018
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Income Per Share
A reconciliation of net loss attributable to the Company in the consolidated statements of comprehensive loss to the numerator for the computation of basic and diluted per share for the years ended December 31, 2016, 2017 and 2018 is as follows:
 
 
 
For the Years Ended December 31,
 
 
 
2016
 
 
2017
 
 
2018
 
 
2018
 
 
 
RMB
 
 
RMB
 
 
RMB
 
 
US$
 
Net loss attributable to Concord Medical Services Holdings Limited
 
 
(261,867
)
 
 
(284,320
)
 
 
(234,875
)
 
 
(34,162
)
Accretion of contingently redeemable noncontrolling interests
 
 
-
 
 
 
-
 
 
 
(124,355
)
 
 
(18,087
)
Numerator for EPS computation
 
 
(261,867
)
 
 
(284,320
)
 
 
(359,230
)
 
 
(52,249
)
 
 
 
 
 
 
 
 
 
For the Years Ended December 31,
 
 
 
2016
 
 
2017
 
 
2018
 
 
2018
 
 
 
 
 
 
 
 
 
Class A
 
 
Class A
 
 
Class B
 
 
Class B
 
 
 
RMB
 
 
RMB
 
 
RMB
 
 
US$
 
 
RMB
 
 
US$
 
Numerator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss attributable to ordinary shareholders used in calculating loss per ordinary share – basic and diluted
 
 
(261,867
)
 
 
(284,320
)
 
 
(28,402
)
 
 
(47,764
)
 
 
(30,827
)
 
 
(4,484
)
Denominator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average number of ordinary shares outstanding used in calculating loss per share – basic and diluted
 
 
130,631,867
 
 
 
130,091,977
 
 
 
118,940,054
 
 
 
118,940,054
 
 
 
11,164,733
 
 
 
11,164,733
 
Loss per share – basic and diluted
 
 
(2.00
)
 
 
(2.19
)
 
 
(2.76
)
 
 
(0.40
)
 
 
(2.76
)
 
 
(0.40
)
 
The effects of share options and Restricted Shares have been excluded from the computation of diluted loss per share for the years ended
December 31, 2016, 2017 and 2018 as their effects would be anti-dilutive.